Novo Nordisk, Waldencast, and Other Big Stocks Plunge in Monday's Pre-Market Session

martes, 25 de noviembre de 2025, 5:41 am ET1 min de lectura
NVO--

Novo Nordisk shares fell 9.3% in pre-market trading after Evoke Phase 3 trials data showed GLP-1 drugs did not demonstrate a statistically significant reduction in Alzheimer's disease progression. Other stocks moving lower include Geospace Technologies, Inventiva ADR, Datavault AI, Waldencast PLC, Pacific Biosciences of California, American Axle & Manufacturing Holdings, Hafnia Ltd, and Getty Images Holdings.

Novo Nordisk, Waldencast, and Other Big Stocks Plunge in Monday's Pre-Market Session

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios